Caricamento...
Hematopoietic Cell Transplantation for Lymphoma in the Era of Genetically Engineered Cellular Therapy: It’s Not Quite Time to Scrap the Old Vehicle for the New CAR
PURPOSE OF THE REVIEW: Second-line platinum-based salvage chemotherapy followed by high-dose chemotherapy and autologous hematopoietic cell transplantation (AHCT) has remained the standard of care (SOC) for relapsed and primary refractory (r/r) DLBCL for greater than 2 decades. In the post-rituximab...
Salvato in:
| Pubblicato in: | Curr Opin Hematol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7428153/ https://ncbi.nlm.nih.gov/pubmed/31170111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOH.0000000000000515 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|